RRC ID 54713
著者 Suehiro Y, Takemoto Y, Nishimoto A, Ueno K, Shirasawa B, Tanaka T, Kugimiya N, Suga A, Harada E, Hamano K.
タイトル Dclk1 Inhibition Cancels 5-FU-induced Cell-cycle Arrest and Decreases Cell Survival in Colorectal Cancer.
ジャーナル Anticancer Res
Abstract BACKGROUND/AIM:5-Fluorouracil (5-FU) is frequently used in colorectal cancer treatment, but with limited success. The aim of the present study was to explore the cytotoxic effects of 5-FU, in combination with inhibition of doublecortin-like kinase 1 (Dclk1), a tumor stem cell marker that regulates pro-survival signaling in colorectal cancer cells, in the human colon cancer cell line, COLO-320.
MATERIALS AND METHODS:The effects of 5-FU treatment plus Dclk1 inhibition on the phosphorylation of checkpoint kinase 1 (Chk1), cell cycle, DNA damage, apoptosis, and cell survival in COLO-320 cells were evaluated.
RESULTS:Combined treatment with 5-FU and a Dclk1 inhibitor, LRRK2-IN-1 (LRRK), decreased 5-FU-induced phosphorylation of Chk1 and canceled 5-FU-induced cell-cycle arrest at the S phase. Combined treatment with 5-FU and LRRK failed to induce poly (ADP-ribose) polymerase 1 (PARP-1) cleavage, but tended to decrease cell survival compared to individual treatment with 5-FU or LRRK.
CONCLUSION:These results indicate that a combination of 5-FU and LRRK may be an effective, novel approach for colorectal cancer therapy.
巻・号 38(11)
ページ 6225-6230
公開日 2018-11-1
DOI 10.21873/anticanres.12977
PII 38/11/6225
PMID 30396941
MeSH Benzodiazepinones / pharmacology* Cell Cycle Checkpoints Cell Line, Tumor Cell Proliferation / drug effects Cell Survival / drug effects Checkpoint Kinase 1 / metabolism* Colonic Neoplasms / drug therapy Colonic Neoplasms / metabolism* Drug Synergism Fluorouracil / pharmacology* Gene Expression Regulation, Neoplastic / drug effects Humans Phosphorylation / drug effects Poly (ADP-Ribose) Polymerase-1 / metabolism* Pyrimidines / pharmacology* Signal Transduction / drug effects
IF 1.935
引用数 5
リソース情報
ヒト・動物細胞 COLO-320(RCB1193)